Fresenius Group Overview

Results Center

To archive

FY/2017 Results

Fresenius reports 14th consecutive record year, aims at strong growth in 2018 and confirms mid-term growth targets
  • 25th consecutive dividend increase proposed
  • Excellent cash flow development
  • Strong Group guidance for 2018

Selected Key Figures FY/2017

selected key figures

1 Constant currency

2 Before special items

3 Before special items; before expenditures for further development of biosimilars business